Arcturus Therapeutics’ biggest vaccine partner has soured on their relationship, and that fallout could unexpectedly free the company to team up with new pharma giants. The story digs into why this breakup matters, what new partners like Sanofi or BioNTech might want from Arcturus’ RNA platform, and what could still derail the upside.Read more

Cidara is betting on a single shot that could protect people from the flu for an entire season, without having to guess which strain will spread. The bigger twist is the idea that governments could stockpile it to blunt the next flu pandemic—if the upcoming trial results cooperate.Read more